Anyang, South Korea

Jae Kyu Shin

This inventor holds 1 USPTO granted patent. Top assignee: Cheiljedang Corp.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jae Kyu Shin. Retrieved from https://idiyas.com/inventor/jae-kyu-shin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jae Kyu Shin: Innovator in Pharmaceutical Chemistry

Introduction

Jae Kyu Shin is a notable inventor based in Anyang-shi, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on cathecol hydrazone derivatives. His research has the potential to impact various therapeutic applications.

Latest Patents

Jae Kyu Shin holds a patent for "Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same." This invention provides novel cathecol hydrazone derivatives of formula (I) or pharmaceutically acceptable salts thereof. The derivatives include various functional groups that enhance their pharmaceutical properties.

Career Highlights

Jae Kyu Shin is currently employed at Cheiljedang Corporation, where he continues to advance his research in pharmaceutical innovations. His work has led to the development of new compounds that may offer improved efficacy in medical treatments.

Collaborations

He collaborates with esteemed colleagues such as Yong Sik Youn and Myung Xik Xiang, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Jae Kyu Shin's contributions to pharmaceutical chemistry exemplify the importance of innovation in developing new therapeutic agents. His work on cathecol hydrazone derivatives showcases his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…